embryonal-botryoid childhood rhabdomyosarcoma
Showing 1 - 25 of 3,311
FFPE Samples From Younger Patients With Rhabdomyosarcoma
Completed
- Alveolar Childhood Rhabdomyosarcoma
- +2 more
-
Jinan, Shandong, ChinaJinan central hospital affiliated to Shandong First Medical Univ
Sep 10, 2023
Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma Trial in Worldwide
Completed
- Adult Rhabdomyosarcoma
- +3 more
- conventional surgery
- +4 more
-
Birmingham, Alabama
- +162 more
Nov 17, 2021
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma Trial in Worldwide (drug, biological,
Active, not recruiting
- Adult Malignant Mesenchymoma
- +10 more
- Irinotecan Hydrochloride
- +6 more
-
Birmingham, Alabama
- +211 more
Dec 9, 2021
CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in
Active, not recruiting
- Central Nervous System Embryonal Tumor With Rhabdoid Features
- +14 more
- Adavosertib
- Irinotecan Hydrochloride
-
Birmingham, Alabama
- +23 more
Oct 7, 2022
Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma Trial in Worldwide (drug,
Suspended
- Alveolar Rhabdomyosarcoma
- +5 more
- Cyclophosphamide
- +8 more
-
Birmingham, Alabama
- +386 more
Aug 18, 2022
Saliva or Buccal Mucosa Samples From Embryonal or Alveolar
Recruiting
- Alveolar Rhabdomyosarcoma
- Embryonal Rhabdomyosarcoma
- Biospecimen Collection
- +2 more
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Aug 8, 2022
Embryonal Tumors of Infancy & Childhood: South Egypt Cancer
Recruiting
- Neoplasms, Embryonal
- Embryonal Neoplasms
-
Assiut, EgyptAssiut University
Jul 24, 2021
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
-
Los Angeles, California
- +1 more
Mar 17, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022
Soft Tissue Sarcoma Trial in Worldwide (trofosfamide, idarubicin, etoposide)
Active, not recruiting
- Soft Tissue Sarcoma
- trofosfamide, idarubicin, etoposide
-
Graz, Austria
- +73 more
Nov 12, 2021
Sarcoma Trial in New York (biological, drug, procedure, radiation)
Active, not recruiting
- Sarcoma
- filgrastim
- +10 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Nov 5, 2021
International PPB/DICER1 Registry
Recruiting
- Pleuropulmonary Blastoma
- +14 more
-
Minneapolis, MinnesotaChildren's Minnesota
Aug 16, 2022
Elucidating Genetic Basis of Pleuropulmonary Blastoma Familial
Active, not recruiting
- Pleuropulmonary Blastoma
- +9 more
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 9, 2022
Rare Embryonal Tumors of Central Nervous System: International
Not yet recruiting
- Embryonal Tumor
-
Yerevan, ArmeniaHematology Center named after prof. R. Yeolyan
Jan 25, 2023
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
Not yet recruiting
- Rhabdomyosarcoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 1, 2023
Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +118 more
Jan 27, 2023
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)
Recruiting
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
- GEM/DOX + TGFBi expanded NK cells
-
Tampa, Florida
- +1 more
Jan 3, 2023
Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto
Recruiting
- Malignant Solid Neoplasm
- +26 more
- Ensartinib
- +2 more
-
Birmingham, Alabama
- +121 more
Aug 24, 2022
Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +30 more
- Larotrectinib Sulfate
-
Birmingham, Alabama
- +123 more
Aug 23, 2022
Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma Trial in United
Recruiting
- Embryonal Rhabdomyosarcoma
- +2 more
- Cyclophosphamide
- +3 more
-
Birmingham, Alabama
- +47 more
Aug 17, 2022
Relapsed/Refractory Rhabdomyosarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma, Ewing Sarcoma Trial in United States (Eribulin
Completed
- Relapsed/Refractory Rhabdomyosarcoma
- +2 more
- Eribulin mesylate
-
Birmingham, Alabama
- +40 more
Mar 18, 2022